Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This study is for women who have had chemotherapy before surgery. It is open to women whose breast cancer cells:
have receptors for the hormones oestrogen or progesterone (is hormone receptor positive)
are
Doctors call this luminal type breast cancer.
Recruitment start: 16 January 2017
Recruitment end: 7 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Andreas Makris
German Breast Group (GBG)
Pfizer
ICR Clinical Trials and Statistics Unit (ICR-CTSU)
Last reviewed: 31 Jan 2018
CRUK internal database number: 14731